Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 USD | -9.84% | -30.20% | -21.54% |
06-24 | Aridis Pharmaceuticals, Inc. Provides Corporate Update on Recent Developments | CI |
06-24 | Aridis Pharmaceuticals, Inc. announced that it expects to receive $0.299 million in funding | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-21.54% | 2.99M | |
+16.12% | 122B | |
+19.75% | 113B | |
+18.95% | 26.49B | |
-24.06% | 19.4B | |
-19.03% | 16.24B | |
-20.40% | 15.4B | |
-46.14% | 15.15B | |
+64.06% | 14.93B | |
+4.49% | 13.52B |
- Stock Market
- Equities
- ARDS Stock
- News Aridis Pharmaceuticals, Inc.
- Aridis Pharmaceuticals, European Regulator Agree on Pneumonia Phase 3 Study Parameters; Shares Jump Premarket